Professor Tredwell studied Chemistry at the University Oxford, where he earned his doctorate in organic chemistry in 2007 before completing postdoctoral research at both the University of Cambridge and the University of Oxford. He established his independent research group at the Max-Planck-Institute für Kohlenforschung in 2015. In 2019, Professor Tredwell joined Cardiff University, appointed jointly between the Schools of Chemistry and Medicine. Since 2026, he is Professor of Pharmaceutical Radiochemistry at TUM.

Prof. Tredwell’s (*1981) research spans the fields of chemical synthesis, radiochemistry, and the development of targeted radiopharmaceuticals for imaging and therapy. He has developed innovative methods and reagents for the ¹⁸F-fluorination of small molecules and biomolecules, enabling the efficient production of positron emission tomography (PET) radiotracers, particularly for neuroimaging. These methods have been widely adopted for both research and clinical studies.